Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
Inv. presentation
Asset disposition

Revolution Medicines, Inc. (RVMD) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/13/2023 8-K Quarterly results
10/11/2023 144 Form 144 - Report of proposed sale of securities:
10/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/02/2023 EFFECT Form EFFECT - Notice of Effectiveness:
09/29/2023 DEFM14A Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
09/29/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
09/28/2023 144 Form 144 - Report of proposed sale of securities:
09/27/2023 S-4/A Form S-4/A - Registration of securities, business combinations: [Amend]
08/17/2023 4 Horn Margaret A (COO) has filed a Form 4 on Revolution Medicines, Inc.
Txns: Sold 3,085 shares @ $30.3571, valued at $93.7k
Sold 1,915 shares @ $30.7993, valued at $59k
Exercised 5,000 options to buy @ $4.09, valued at $20.5k
08/15/2023 144 Form 144 - Report of proposed sale of securities:
08/08/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/08/2023 8-K Quarterly results
Docs: "Revolution Medicines Reports Second Quarter 2023 Financial Results and Update on Corporate Progress Company to provide clinical updates for RMC-6236 at Triple Meeting and ESMO Congress 2023 and initial clinical findings for RMC-6291 at Triple Meeting Planning underway for one or more single agent pivotal trials with RMC-6236 and the first combination study of RMC-6236 and RMC-6291 Announced acquisition of EQRx, Inc. expected to add more than $1 billion in additional capital to balance sheet Webcast today at 4:30 p.m. Eastern Time REDWOOD CITY, Calif., August 8, 2023"
08/03/2023 4 Kelsey Stephen Michael (See Remarks) has filed a Form 4 on Revolution Medicines, Inc.
Txns: Sold 16,666 shares @ $29.1913, valued at $486.5k
Sold 16,666 shares @ $32.4, valued at $540k
08/02/2023 144 Form 144 - Report of proposed sale of securities:
08/01/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/01/2023 425 Form 425 - Prospectuses and communications, business combinations:
08/01/2023 425 Form 425 - Prospectuses and communications, business combinations:
08/01/2023 425 Form 425 - Prospectuses and communications, business combinations:
08/01/2023 425 Form 425 - Prospectuses and communications, business combinations:
08/01/2023 425 Form 425 - Prospectuses and communications, business combinations:
08/01/2023 425 Form 425 - Prospectuses and communications, business combinations:
08/01/2023 144 Form 144 - Report of proposed sale of securities:
08/01/2023 425 Form 425 - Prospectuses and communications, business combinations:
08/01/2023 8-K Quarterly results
07/31/2023 144 Form 144 - Report of proposed sale of securities:
06/30/2023 SC 13G BIOTECHNOLOGY VALUE FUND L P reports a 7.1% stake in Revolution Medicines, Inc.
06/16/2023 SC 13G/A EcoR1 Capital, LLC reports a 6.8% stake in Revolution Medicines, Inc.
06/12/2023 4 Borellini Flavia (Director) has filed a Form 4 on Revolution Medicines, Inc.
Txns: Granted 5,200 shares @ $0
Granted 18,400 options to buy @ $24.84, valued at $457.1k
06/12/2023 4 Borisy Alexis (Director) has filed a Form 4 on Revolution Medicines, Inc.
Txns: Granted 5,200 shares @ $0
Granted 18,400 options to buy @ $24.84, valued at $457.1k
06/12/2023 4 Weber Barbara (Director) has filed a Form 4 on Revolution Medicines, Inc.
Txns: Granted 5,200 shares @ $0
Granted 18,400 options to buy @ $24.84, valued at $457.1k
06/12/2023 4 ANDERSON ELIZABETH M (Director) has filed a Form 4 on Revolution Medicines, Inc.
Txns: Granted 5,200 shares @ $0
Granted 18,400 options to buy @ $24.84, valued at $457.1k
06/12/2023 4 SCHMIDT ERIC THOMAS (Director) has filed a Form 4 on Revolution Medicines, Inc.
Txns: Granted 5,200 shares @ $0
Granted 18,400 options to buy @ $24.84, valued at $457.1k
06/12/2023 4 Patel Sushil (Director) has filed a Form 4 on Revolution Medicines, Inc.
Txns: Granted 5,200 shares @ $0
Granted 18,400 options to buy @ $24.84, valued at $457.1k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy